AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera
Business Wire India AOP Health announced new results on ropeginterferon alfa-2b (BESREMi®) from its clinical study CONTINUATION-PV in patients with polycythaemia vera (PV), a rare blood cancer. Professor Heinz Gisslinger…